Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen, Inc. - Common Stock (NQ: OCGN )

0.7179 +0.0152 (+2.16%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Is Ocugen a Buy?
This biotech obtained rights to sell a highly effective coronavirus vaccine in the U.S. Can it pull it off? 
Via The Motley Fool
Exposures COVID-19
58 Biggest Movers From Yesterday
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the full details of its Phase 2 trial... 
Via Benzinga
If You Want to Roll the Dice on Ocugen Stock, Understand the Game You’re Playing
In this crazy Reddit-driven stock market, it's still important to understand why OCGN stock is hot. And why it's dangerous. 
Via InvestorPlace
Here's Why Snap And Ocugen Are Popping Off Today
Snap Inc (NYSE:SNAP) shares are trading higher by 4.5% in Friday’s pre-market ... 
Via Benzinga
Why Ocugen's Stock Is Surging Today
Ocugen, Inc. (NASDAQ: OCGN) shares are trading higher after the White House announced it would immediately make available specific raw materials needed by India to make COVID-19... 
Via Benzinga
Ocugen Stock Is Tethered To Its Covid-19 Vaccine
OCGN stock looks to have bottomed and is once againt moving higher, raising questions of whther investors should now take a position. 
Via InvestorPlace
Exposures COVID-19
Mid-Afternoon Market Update: Nasdaq Surges Over 100 Points; Reviva Pharmaceuticals Shares Spike Higher
Toward the end of trading Monday, the Dow traded down 0.08% to 34,015.96 while the NASDAQ rose 0.83% to 14,133.38. The S&P also rose, gaining 0.24% to 4,190.04. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Reviva Pharmaceuticals (NASDAQ:RVPH) shares rose 72.91% to $7.47 during Monday's regular session. Reviva Pharmaceuticals's stock is trading at a volume of... 
Via Benzinga
Mid-Day Market Update: Proofpoint Jumps Following Acquisition News; Fortuna Silver Mines Shares Slide
Midway through trading Monday, the Dow traded up 0.14% to 34,092.01 while the NASDAQ rose 0.59% to 14,099.52. The S&P also rose, gaining 0.31% to 4,193.06. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
38 Stocks Moving In Monday's Mid-Day Session
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) surged 46.9% to $6.25 after the company announced the full details of its Phase 2 trial evaluating its lead drug... 
Via Benzinga
Why Investors Might Want to Start Getting Bullish on Ocugen
As the vaccine rollout accelerates, investors remain on the fence as to how the Covaxin vaccine will impact OCGN stock in the near term. 
Via InvestorPlace
Exposures COVID-19
Thinking About Buying Stock In Nio, Facebook, Futu Or Ocugen?
Nio Inc - ADR (NYSE: NIO) shares are trading higher by 1.75% at $41.80 Monday morning after CLSA analyst Soobin Park has initiated coverage of the Chinese electric carmaker... 
Via Benzinga
OCGN Stock: The White House News That Has Ocugen Climbing Today
OCGN stock is gaining on Monday following an announcement that the White House will back India in its Covid-19 fight. 
Via InvestorPlace
Exposures COVID-19
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Ocugen (NASDAQ:OCGN) shares rose 13.81% to $10.96 during Monday's pre-market session. The market value of their outstanding shares is at $2.0 billion. Advaxis... 
Via Benzinga
21 Stocks Moving in Monday's Pre-Market Session
Gainers Ocugen, Inc. (NASDAQ: OCGN) shares rose 20.6% to $11.61 in pre-market trading. Ocugen’s COVID-19 vaccine partner, India-based Bharat Biotech International Ltd.,... 
Via Benzinga
Exposures COVID-19
A Peek Into The Markets: US Stock Futures Mixed; Tesla Earnings In Focus
Pre-open movers U.S. stock futures traded mixed in early pre-market trade after the Dow Jones climbed more than 200 points in the previous session. Investors are awaiting earnings... 
Via Benzinga
Topics Stocks
Exposures US Equities
Ocugen's COVID-19 Vaccine Partner To Charge Twice As Much As Main Indian Rival Astrazeneca
Biopharmaceutical company Ocugen Inc.’s (NASDAQ: OCGN) COVID-19 vaccine partner, India-based Bharat Biotech International Ltd., will charge as much as double its main rival... 
Via Benzinga
Exposures COVID-19
Here's Why Ocugen Stock Rocketed 47% Today -- and Then Gave Up Almost All Its Gains
The biotech is seeking to cash in on the recent rally in its stock price. 
Via The Motley Fool
Exposures COVID-19
Ocugen Looks Less Interesting With Each Passing Shot
OCGN stock popped in February as investors anticipated revenue from a Covid-19 vaccine partnership. But the U.S. looks to be well supplied. 
Via InvestorPlace
Exposures COVID-19
32 Stocks Moving In Friday's Mid-Day Session
Gainers Sypris Solutions, Inc. (NASDAQ: SYPR) shares climbed 24.7% to $3.50 after the company said its electronics unit has won a contract for deep space program. MicroVision,... 
Via Benzinga
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... 
Via Benzinga
Exposures Product Safety
Ocugen Stock Relief Pop Is Great, But It Needs More
OCGN stock soared on great news but it is now going into a prior failure level. Investors can hold it long term but short term, it's tricky. 
Via InvestorPlace
OCGN Stock: The Big COVAXIN News That Prompted 40% Gains in Ocugen
OCGN stock is seeing upward momentum as it looks to become just the fourth vaccine option available in the U.S. 
Via InvestorPlace
Exposures COVID-19
Global Market For Sleep Aid Devices Could Reach $112.7 Billion By 2025
Via FinancialNewsMedia
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Jaguar Health (NASDAQ:JAGX) shares moved upwards by 11.8% to $1.61 during Friday's pre-market session. The market value of their outstanding shares is at $205.... 
Via Benzinga
25 Stocks Moving in Friday's Pre-Market Session
Gainers Sypris Solutions, Inc. (NASDAQ: SYPR) shares rose 42% to $3.99 in pre-market trading after the company said its electronics unit has won a contract for deep space program... 
Via Benzinga
Is It Too Late to Buy Ocugen Stock?
The shares have soared on good news from its potential coronavirus vaccine. 
Via The Motley Fool
Exposures COVID-19
44 Biggest Movers From Yesterday
Gainers KnowBe4, Inc. (NASDAQ: KNBE) shares jumped 50.9% to close at $24.14 on Thursday after the company priced its IPO at $16 per share. Neuropace, Inc. (NASDAQ: NPCE) shares... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Johnson & Johnson COVID-19 Vaccine Could Make Its Way To India By July
Johnson & Johnson’s (NYSE: JNJ) single-shot COVID-19 vaccine is expected to be imported to India for the fill and finish process over the next two to three months,... 
Via Benzinga
Exposures COVID-19
Why Ocugen Shares Skyrocketed Today
Ocugen Inc (NASDAQ: OCGN) shares soared 42.9% in the regular session and another 11% in the after-hours session on Thursday. What Happened: The shares surged following positive... 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.